Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis

被引:14
作者
Chen Delong [1 ,2 ]
Wang Haibin [3 ,4 ]
Meng, Zhang [1 ,2 ]
Shan, Jiang [1 ,2 ]
Chi, Zhou [2 ,3 ]
Bin, Fang [2 ,3 ,4 ]
Peng, Chen [2 ,3 ,4 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Med Sch 1, Baiyun Area, 12 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
[2] Guangzhou Univ Chinese Med, Lab Orthopaed & Traumatol, Chinese Med Lingnan Med Res Ctr, Baiyun Area, 12 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
[3] Guangzhou Univ Chinese Med, Orthoped Dept, Affiliated Hosp 1, Baiyun Area, 16 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
[4] Guangzhou Univ Chinese Med, Hip Ctr, Baiyun Area, 16 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
LncRNAs; Osteosarcoma; Prognosis; Meta-analysis; POOR-PROGNOSIS; UP-REGULATION; INHIBITS PROLIFERATION; CELL-PROLIFERATION; PROMOTES; PROGRESSION; MIGRATION; INVASION; SURVIVAL; CANCER;
D O I
10.1016/j.jbo.2018.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Numerous studies have reported the relationship between Long non-coding RNAs (LncRNAs) expression and prognosis of osteosarcoma, but less consensus has been reached. Our meta-analysis was conducted to quantitatively assess the relationship between the expression of LncRNAs, prognosis and clinical pathology in osteosarcoma development. Methods: PubMed, Embase, Web of Science, The Cochrane Library, SionMed, CNKI and WanFang databases were carefully searched to identify eligible studies. The pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to evaluate the prognostic significance of LncRNAs expression in osteosarcoma. Moreover, meta-regression analysis and subgroup analysis were carried out to explore the potential sources of heterogeneity. Results: A total of 20 studies comprising 1749 patients were included in present meta-analysis. The results showed that the over-expression of LncRNA had a significant correlation with overall survival (OS) (HR = 2.16, 95% CI: 1.68-2.79), and was not related to disease free survival (DFS) (HR = 0.71, 95% CI: 0.05-9.53). Subgroup analysis further indicated that LncRNA transcription level was significantly associated with alkaline phosphatase (HR = 2.13, 95% CI: 1.58-2.88), tumor size (< 8/ >= 8: HR = 1.97, 95% CI: 1.55-2.62), metastasis (yes/no: HR = 2.14,95% CI: 1.15-3.97), distant metastasis(presence/absence: HR = 4.02, 95% CI: 3.05-5.23) and Enneking stage(IIA /IIB-III: HR = 3.2, 95% CI: 2.48-4.14), but not associated with age (<= 25/> 25: HR = 1.01, 95% CI: 0.78-1.3), gender(female/male: HR = 1.15, 95% CI: 0.96-1.37), tumor site (femur, tibia/elsewhere: HR = 1.15, 95% CI: 0.94-1.4) and chemotherapy (yes/no: HR = 1.45, 95% CI: 0.46-4.63). Conclusions: This study demonstrated that abnormal LncRNAs expression might be potential prognostic markers to predict worse overall survival in osteosarcoma patients. However, the cut-off values may be the source of heterogeneity.
引用
收藏
页码:76 / 90
页数:15
相关论文
共 51 条
[1]  
Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872
[2]   Bone Tumors in Adolescents and Young Adults [J].
Bielack, Stefan S. ;
Carrle, Dorothe ;
Hardes, Jendrik ;
Schuck, Andreas ;
Paulussen, Michael .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2008, 9 (01) :67-80
[3]   The IncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma [J].
Cai, Lijun ;
Lv, Jinhan ;
Zhang, Yinquan ;
Li, Junhong ;
Wang, Yinong ;
Yang, Huilin .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (11) :2654-2662
[4]   Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription [J].
Chen, Fenyong ;
Mo, Jiadong ;
Zhang, Li .
TUMOR BIOLOGY, 2016, 37 (10) :13403-13412
[5]   Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis [J].
Chi, Shuqi ;
Shen, Lina ;
Hua, Teng ;
Liu, Shuangge ;
Zhuang, Guobing ;
Wang, Xiaoxiao ;
Zhou, Xing ;
Wang, Guozhen ;
Wang, Hongbo .
ONCOTARGET, 2017, 8 (45) :79061-79072
[6]   Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma [J].
Cong, Menglin ;
Li, Jianmin ;
Jing, Rui ;
Li, Zhenzhong .
TUMOR BIOLOGY, 2016, 37 (07) :9441-9450
[7]   Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database [J].
Duchman, Kyle R. ;
Gao, Yubo ;
Miller, Benjamin J. .
CANCER EPIDEMIOLOGY, 2015, 39 (04) :593-599
[8]   A systematic review of p53 as a biomarker of survival in patients with osteosarcoma [J].
Fu, Hai-Liang ;
Shao, Lin ;
Wang, Qiang ;
Jia, Tao ;
Li, Ming ;
Yang, Da-Ping .
TUMOR BIOLOGY, 2013, 34 (06) :3817-3821
[9]  
Gao KT, 2016, EUR REV MED PHARMACO, V20, P3561
[10]   Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma [J].
Guo, Junyu ;
Reddick, Wilburn E. ;
Glass, John O. ;
Ji, Qing ;
Billups, Catherine A. ;
Wu, Jianrong ;
Hoffer, Fredric A. ;
Kaste, Sue C. ;
Jenkins, Jesse J. ;
Ortega Flores, Ximena C. ;
Quintana, Juan ;
Villarroel, Milena ;
Daw, Najat C. .
CANCER, 2012, 118 (15) :3776-3785